FORM8.3
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013
DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE
1. KEYINFORMATION
Nameofpersondealing(Note1)State Street Global Advisors & AffiliatesCompanydealtinAvadel Pharmaceuticals plcClassofrelevantsecuritytowhich
the dealingsbeingdisclosedrelate(Note2)
$0.01 ordinary shares
Dateofdealing6th January 20262. INTERESTSANDSHORTPOSITIONS
(110) Interestsandshortpositions(followingdealing)intheclassofrelevantsecurity dealtin (Note 3)
LongShort Number(%)Number(%)(1)Relevantsecurities2,294,8792.35606% (2)Derivatives(otherthanoptions)N/AN/A (3)Optionsandagreementsto
purchase/sell
N/AN/A Total2,294,8792.35606%
(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,other thanthe classdealtin (Note 3)
Classofrelevantsecurity:LongShort Number(%)Number(%)(1)RelevantsecuritiesN/A (2)Derivatives(otherthanoptions)N/A (3)Optionsandagreementstopurchase/sellN/A TotalN/A 3. DEALINGS (Note 4)
(110) Purchasesandsales
Purchase/saleNumberofrelevantsecuritiesPriceperunit (Note 5)Purchase4,86821.50Purchase89621.50
(b) Derivativestransactions(otherthanoptionstransactions)
Productname,
e.g.CFD
Natureoftransaction
(Note 6)
Numberofrelevantsecurities
(Note 7)
Priceperunit
(Note 5)
N/A
(c) Optionstransactionsinrespectofexistingrelevantsecurities
(i) Writing,selling,purchasingorvarying
Productname,
e.g.calloption
Writing,selling,
purchasing
varyingetc.
Numberof
securities towhich
theoption relates
(Note 7)
Exercise
price
Type,e.g.
American,
Europeanetc.
Expiry
date
Optionmoney
paid/received
perunit (Note 5)
N/A (ii) ExercisingProductname,
e.g.calloption
NumberofsecuritiesExercisepriceper
unit (Note 5)
N/A (d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)Natureoftransaction
(Note 8)
DetailsPriceperunit
(ifapplicable) (Note 5)
N/A 4. OTHERINFORMATION
Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives
Fulldetails of any agreement, arrangement or understanding betweenthepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisform or relating to the voting rights or future acquisition or disposal ofany relevantsecuritiestowhichanyderivativereferredtoonthisformisreferenced.Ifnone,this shouldbestated.N/AIsaSupplementalForm8attached? (Note 9)
NO
Date of disclosure
7th-January-2026
Contactname
Divya K
Telephonenumber
+918067452364
IfaconnectedEFM,nameofofferee/offeror withwhichconnected
N/A
IfaconnectedEFM,statenatureof connection (Note 10)
N/A
